Sally C. Pipes
Uncategorized
A Republican healthcare package remains within reach
The House is expected to vote this week on healthcare reform legislation. The upcoming action comes on the heels of two failed votes in the Senate: one a Democratic bill that would’ve extended COVID-19-era enhanced Affordable Care Act subsidies for exchange coverage and the other a Republican bill that would ...
Commentary
Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients
Chaos has become the norm at the U.S. Food and Drug Administration. And it’s putting American patients, not to mention our country’s world-leading life sciences sector, at risk. Earlier this year, roughly 3,500 FDA employees were laid off. The agency’s Center for Drug Evaluation and Research, which oversees prescription and ...
Commentary
Democrats Can’t End Private-Sector Drug Innovation Fast Enough
In November, a group of Democrats in the U.S. House made clear that they’ll sacrifice medical innovation for lower drug prices if they ever reclaim Congress. Patients today and tomorrow will be the losers in that trade. Read the op-ed here.
Commentary
The real story behind Trump’s GLP-1 price cut: Markets still rule
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare and Medicaid. Both firms have also agreed to sell the drugs at lower prices on Trump’s yet-to-be-developed online marketplace for prescription drugs, TrumpRx. Lilly and ...
Commentary
GAO Provides Yet More Evidence for Why Enhanced Obamacare Subsidies Must Expire
Defrauding the government through Obamacare’s insurance exchanges is shockingly easy, per a new government report. The study found that federal insurance subsidies were granted for 90 percent of the fake exchange accounts set up as part of a Government Accountability Office investigation — at a cost of more than $10,000 ...
Commentary
Despite Dems’ protests, affordable health plans are about to multiply
Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
Blog
How did the US become the world’s center of pharmaceutical innovation?
What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Commentary
Trade Policy Is The Right Way To Fight Foreign Freeloading
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
Commentary
‘Soak the Rich’ Won’t Rescue Calif. Healthcare
A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Commentary
Competition, not price controls, just slashed GLP-1 prices
Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...
A Republican healthcare package remains within reach
The House is expected to vote this week on healthcare reform legislation. The upcoming action comes on the heels of two failed votes in the Senate: one a Democratic bill that would’ve extended COVID-19-era enhanced Affordable Care Act subsidies for exchange coverage and the other a Republican bill that would ...
Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients
Chaos has become the norm at the U.S. Food and Drug Administration. And it’s putting American patients, not to mention our country’s world-leading life sciences sector, at risk. Earlier this year, roughly 3,500 FDA employees were laid off. The agency’s Center for Drug Evaluation and Research, which oversees prescription and ...
Democrats Can’t End Private-Sector Drug Innovation Fast Enough
In November, a group of Democrats in the U.S. House made clear that they’ll sacrifice medical innovation for lower drug prices if they ever reclaim Congress. Patients today and tomorrow will be the losers in that trade. Read the op-ed here.
The real story behind Trump’s GLP-1 price cut: Markets still rule
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 weight-loss drugs dispensed through Medicare and Medicaid. Both firms have also agreed to sell the drugs at lower prices on Trump’s yet-to-be-developed online marketplace for prescription drugs, TrumpRx. Lilly and ...
GAO Provides Yet More Evidence for Why Enhanced Obamacare Subsidies Must Expire
Defrauding the government through Obamacare’s insurance exchanges is shockingly easy, per a new government report. The study found that federal insurance subsidies were granted for 90 percent of the fake exchange accounts set up as part of a Government Accountability Office investigation — at a cost of more than $10,000 ...
Despite Dems’ protests, affordable health plans are about to multiply
Obamacare premiums are climbing yet again during open enrollment. But there’s also some good news for cost-conscious shoppers ― a new way to secure affordable coverage without forgoing access to care. This year, many people can buy low-cost “catastrophic” health plans for the very first time. Combine one of these ...
How did the US become the world’s center of pharmaceutical innovation?
What kinds of policies helped the US surpass Great Britain to become the world’s center of pharmaceutical innovation? I think it was a combination of shrewd reforms on the part of the United States, and self-destructive reforms on the part of Europe and other developed nations. In the 1970s, Europe ...
Trade Policy Is The Right Way To Fight Foreign Freeloading
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports. It’s a perfect example of how the ...
‘Soak the Rich’ Won’t Rescue Calif. Healthcare
A group of unions in California has proposed a new plan for paying for healthcare — soak the rich. That’s the idea behind the Billionaire Tax Act, a 2026 ballot initiative that would impose a 5% tax on the state’s billionaires in order to raise money for healthcare programs and ...
Competition, not price controls, just slashed GLP-1 prices
Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay as little as $349 for a monthly dose of these medicines. The company has also dropped ...